Listen to our latest Investing Matters Podcast episode 'Uncovering opportunities with investment trusts' with The AIC's Richard Stone here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksApq Global Regulatory News (APQ)

Share Price Information for Apq Global (APQ)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 5.50
Bid: 4.00
Ask: 7.00
Change: 0.00 (0.00%)
Spread: 3.00 (75.00%)
Open: 5.50
High: 5.50
Low: 5.50
Prev. Close: 5.50
APQ Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Successful Fundraising - Placing of £10.21 million

23 Jan 2018 07:00

RNS Number : 5885C
APQ Global Limited
23 January 2018
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, CANADA, JAPAN, AUSTRALIA, SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE IT IS UNLAWFUL TO DISTRIBUTE THIS ANNOUNCEMENT. THE INFORMATION CONTAINED HEREIN DOES NOT CONSTITUTE AN OFFER OF SECURITIES FOR SALE IN ANY JURISDICTION, INCLUDING IN THE UNITED STATES OF AMERICA, CANADA, JAPAN, AUSTRALIA OR SOUTH AFRICA.

APQ Global Limited ("APQ" or the "Company")

Successful Fundraising

Placing of £10.21 million of 3.5 per cent. convertible unsecured loan stock 2024 (the "Placing") at £5,150 per £5,000 nominal

APQ, the emerging markets diversified income company incorporated in Guernsey which is listed on The International Stock Exchange Limited and admitted to trading on AIM, is pleased to announce that further to the announcements of 1 December and 22 December 2017, it has successfully raised £10,207,300 through the issue of 1,982 units of 3.5 per cent. convertible unsecured loan stock 2024 (the "CULS") in denominations of £5,000 nominal each, at an issue price of £5,150 per unit (the "Placing").

The requisite authority to issue the CULS was sought and granted at the Company's extraordinary general meeting held on 21 December 2017. Application has been made for admission to trading on the International Securities Market, the London Stock Exchange's segment for fixed income securities, of the CULS with dealings expected to commence on 26 January 2018 ("Admission").

The issue of the CULS pursuant to the Placing builds upon the successful fundraising of £20.09 million through the issue of the Company's existing CULS in September 2017, which provided the Company with attractive long-term structural gearing at a fixed cost. The Placing strengthens the Board's confidence that employing gearing on this basis will enable the Company to generate increased total returns over the longer term.

The interest rate on the CULS will be 3.5 per cent. per annum, payable quarterly in arrear on 31 March, 30 June, 30 September and 31 December in each year on the nominal amounts, with the first interest payment due in early April 2018 for the period from Admission to 31 March 2018.

Holders of the CULS will be entitled to convert their CULS into Ordinary Shares on a quarterly basis throughout the life of the CULS, commencing 31 March 2018, and all outstanding CULS will be repayable at par (plus any accrued interest) on 30 September 2024. The initial conversion price is 105.358 pence, being a 10 per cent. premium to the unaudited Book Value per Ordinary Share on 31 July 2017.

The Directors intend to apply the net proceeds of the Placing, expected to be approximately £9.8 million, in line with the Company's business and investment strategy.

Old Mutual, a substantial Shareholder of the Company (as defined in the AIM Rules), is investing in the Placing, with such participation constituting a related party transaction for the purposes of the AIM Rules. The Directors consider, having consulted with the Company's nominated adviser, N+1 Singer, that the terms of the Placing with Old Mutual are fair and reasonable insofar as the Shareholders are concerned.

The Company also announces that it has today published admission particulars required to be produced under the rules of the International Securities Market and containing details of the Placing and the CULS ("Admission Particulars"). The Admission Particulars are available to download from the Company's website, apqglobal.com.

N +1 Singer is acting as placing agent, nominated adviser and broker to the Company.

Enquiries:

APQ Global LimitedBart Turtelboom - Chief Executive Officer

020 3478 9708

N+1 Singer - Nominated Adviser and BrokerJames Maxwell / Lauren Kettle / Jens Ehrenberg

020 7496 3000

Carey Group - TISE sponsorRebecca Booth / Claire Torode

01481 737 285 / 01481 737 277

Buchanan Communication - Financial PRCharles Ryland / Victoria Hayns

020 7466 5000

Expected Timetable

Admission Particulars published

23 January 2018

Admission and commencement of dealings in CULS on the London Stock Exchange's International Securities Market

8.00 a.m. on 26 January 2018

CREST stock accounts credited with CULS issued in uncertificated form

8.00 a.m. on 26 January 2018

Definitive certificates for CULS issued in certificated form

within 10 Business Days of Admission

 

TIDM and ISIN of the CULS

TIDM: APQ1

ISIN: GG00BF7PL093

 

Notes to Editors

APQ Global Limited

APQ Global (ticker: APQ LN) is a global emerging markets income company with interests across Asia, Latin America, Eastern Europe, the Middle East and Africa. The Company's objective is to steadily grow earnings to deliver attractive returns and capital growth to shareholders. This objective is achieved through a combination of revenue generating operating activities and investing in growing businesses across emerging markets. APQ Global manages a well-diversified and liquid portfolio of equities and bonds. In addition, APQ Global takes strategic stakes in selected businesses and plans to take operational control of companies through the acquisition of minority and majority stakes in companies with a focus on emerging markets.

For more information, please visit apqglobal.com.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IOEPGUWCGUPRGMP
Date   Source Headline
13th Jun 20244:30 pmRNSChange of Registered Office
24th May 20247:00 amRNSBook Value Report
3rd Apr 20247:00 amRNSTrading Update
22nd Mar 20247:00 amRNSBook Value Report
6th Feb 20245:00 pmRNSBook Value Report
19th Dec 20235:00 pmRNSBook Value Report
20th Nov 20235:06 pmRNSBook Value Report
17th Oct 20235:00 pmRNSBook Value Report
27th Sep 202312:00 pmRNSBook Value Report
21st Sep 20231:00 pmRNSDirectorate Change
17th Aug 20235:00 pmRNSBook Value Report
9th Aug 20235:01 pmRNSResult of AGM
14th Jul 20231:00 pmRNSBook Value Report
10th Jul 202312:00 pmRNSNotice of AGM
22nd Jun 20231:00 pmRNSBook Value Report
6th Jun 20237:00 amRNSFinal results for the year to 31 December 2022
17th May 20231:00 pmRNSBook Value Report
20th Apr 202310:00 amRNSResult of Tender Offer for CULS
18th Apr 20237:00 amRNSBook Value Report
3rd Apr 20237:00 amRNSTender Offer for CULS
17th Mar 20237:00 amRNSBook Value Report
21st Feb 20239:00 amRNSBook Value Report
27th Jan 20237:00 amRNSBook Value Report
16th Dec 20225:00 pmRNSBook Value Report
16th Nov 20225:00 pmRNSBook Value Report
17th Oct 20227:00 amRNSBook Value Report
17th Oct 20227:00 amRNSBook Value Report
4th Oct 20227:00 amRNSIssue of Equity and PDMR/Director Shareholding
29th Sep 20227:00 amRNSInterim results for six months ended 30 June 2022
14th Sep 20221:00 pmRNSBook Value Report
16th Aug 202212:00 pmRNSBook Value Report
15th Aug 20224:00 pmRNSChange of Registered Office
10th Aug 202211:00 amRNSResult of AGM
25th Jul 20227:00 amRNSIssue of Equity and PDMR/Director Shareholding
15th Jul 202212:30 pmRNSBook value report
11th Jul 20227:00 amRNSNotice of AGM
16th Jun 20227:00 amRNSBook Value Report
1st Jun 20227:00 amRNSFinal results for the year to 31 December 2021
19th May 20227:00 amRNSBook Value Report
27th Apr 20227:00 amRNSIssue of Equity and PDMR/Director Shareholding
14th Apr 20228:00 amRNSQuarterly Update
14th Apr 20227:00 amRNSBook Value Report
15th Mar 20227:00 amRNSBook Value Report
21st Feb 20227:00 amRNSBook Value Report
28th Jan 20227:00 amRNSBook Value Report
21st Jan 20227:00 amRNSIssue of Equity and PDMR/Director Shareholding
20th Dec 20217:00 amRNSBook Value Report
17th Nov 20217:00 amRNSBook Value Report
11th Nov 20217:00 amRNSRepurchase of Convertible Preference Shares
9th Nov 20217:00 amRNSRepurchase of Convertible Preference Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.